<DOC>
	<DOCNO>NCT02754453</DOCNO>
	<brief_summary>There three different phase study : 1 . Screening phase determine eligible participate study . 2 . Study phase , entail diet activity , exercise finally self monitoring goal . 3 . End treatment phase ask complete questionnaire .</brief_summary>
	<brief_title>Weight Regain Study After Bariatric Surgery-A Pilot Project</brief_title>
	<detailed_description>The purpose study determine feasibility group treatment program individual experience weight regain bariatric surgery evaluate effectiveness group treatment program . There little information program assist patient experience weight regain bariatric surgery . This treatment program focus behavioral change activity .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Weight regain postRYGB least 5 kg since reach weight nadir . Male Female age 18 65 . Undergone RYGB 12 36 month prior . Ability read , write understand English . Experienced least 25 % total weight loss since surgery . BMI least 27 kg/m . Weight regain half excess body weight . These case refer back surgeon . Taking Weightsuppressing medication ( e.g . phentermine , bupropion ) On medication know cause weight gain Change smoking status past three month Change antidepressant psychotropic medication dosage past six week Change psychotherapy status past six week Current purge behavior occur per week past six week ( vomit laxative/diuretic use purpose weight loss Current alcohol abuse dependence illicit drug use past three month Active bipolar psychotic spectrum disorder Current suicidality homicidality Severe neuropsychological disease ( history seizure , uncontrolled hypertension Condition associate cognitive dysfunction ( e.g . Alzheimer 's dementia , neurological condition ) Medically unstable condition one investigator feel put participant risk study Functional limitationsnot able walk 2 block without assistance Exercise contraindicate ( e.g. , severe cardiovascular disease , uncontrolled hypertension , hematocrit. &lt; 30 % , chronic kidney disease , severe pulmonary disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Weight Regain</keyword>
	<keyword>Group Treatment</keyword>
	<keyword>Weight Loss</keyword>
</DOC>